Search research articles
Contact Us
Filters
Showing results (281-290 of 316) with videos related to
Page
of 32
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2011
Internalization of oncolytic reovirus by human dendritic cell carriers protects the virus from neutralization
Elizabeth J Ilett, Montserrat Bárcena, Fiona Errington-Mais, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2008
Tumor infection by oncolytic reovirus primes adaptive antitumor immunity
Robin J Prestwich, Fiona Errington, Elizabeth J Ilett, et al.
Oncoimmunology
|
January 4, 2018
Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models
Katherine E Lewis, Mark J Selby, Gregg Masters, et al.
British Journal of Cancer
|
January 1, 1997
Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer
G Velikova, R E Banks, A Gearing, et al.
Molecular Therapy Oncolytics
|
October 9, 2018
APOBEC3 Mediates Resistance to Oncolytic Viral Therapy
Amanda L Huff, Phonphimon Wongthida, Timothy Kottke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2014
Biomarkers and response to bevacizumab--response
Fiona Collinson, Michelle Hutchinson, Rachel A Craven, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2013
Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection
Fiona Collinson, Michelle Hutchinson, Rachel A Craven, et al.
Leukemia
|
March 28, 2015
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia
C Parrish, G B Scott, G Migneco, et al.
Cancer Immunology Research
|
May 30, 2014
In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates
Changyu Wang, Kent B Thudium, Minhua Han, et al.
Hematological Oncology
|
October 12, 2000
Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests
F E Davies, A C Rawstron, G Pratt, et al.
Page
of 32
Search research articles
Search
Showing results (281-290 of 316) with videos related to
Sort By:
Page
of 32
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2011
Internalization of oncolytic reovirus by human dendritic cell carriers protects the virus from neutralization
Elizabeth J Ilett, Montserrat Bárcena, Fiona Errington-Mais, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2008
Tumor infection by oncolytic reovirus primes adaptive antitumor immunity
Robin J Prestwich, Fiona Errington, Elizabeth J Ilett, et al.
Oncoimmunology
|
January 4, 2018
Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models
Katherine E Lewis, Mark J Selby, Gregg Masters, et al.
British Journal of Cancer
|
January 1, 1997
Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer
G Velikova, R E Banks, A Gearing, et al.
Molecular Therapy Oncolytics
|
October 9, 2018
APOBEC3 Mediates Resistance to Oncolytic Viral Therapy
Amanda L Huff, Phonphimon Wongthida, Timothy Kottke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2014
Biomarkers and response to bevacizumab--response
Fiona Collinson, Michelle Hutchinson, Rachel A Craven, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2013
Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection
Fiona Collinson, Michelle Hutchinson, Rachel A Craven, et al.
Leukemia
|
March 28, 2015
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia
C Parrish, G B Scott, G Migneco, et al.
Cancer Immunology Research
|
May 30, 2014
In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates
Changyu Wang, Kent B Thudium, Minhua Han, et al.
Hematological Oncology
|
October 12, 2000
Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests
F E Davies, A C Rawstron, G Pratt, et al.
Page
of 32